Minimal Survival Differences Among RT Modalities for Intermediate-Risk PCa
In a study, brachytherapy was associated with only a slight survival advantage over dose-escalated EBRT.
All articles by Natasha Persaud
Neoadjuvant Chemo May Improve Overall Survival in UTUC
Survival was significantly improved in patients with greater disease burden.
HIF-PHIs Show Short-Term Efficacy and Safety
A current meta-analysis of HIF-PHIs showed that these drugs improve the response rate of hemoglobin and decrease hepcidin levels.
PARP Inhibitor Prolongs Overall Survival in mCRPC
An overall survival advantage with olaparib was particularly observed among patients with BRCA1 or BRCA2 alterations.
Factors Contributing to Darbepoetin Responsiveness in CKD
In a Japanese study, approximately 1 in 8 CKD patients with anemia failed to respond to darbepoetin alfa therapy.
Investigators ID Predictors of CKD Progression After Radical Nephrectomy
Kidney microstructural features appear predictive of progressive CKD and mortality following radical nephrectomy.
EAU Issues Updated UTUC Guidelines
The 2020 update highlights the importance of accurate diagnosis of upper tract urothelial carcinoma, risk stratification, close follow-up of patients receiving kidney-sparing management, and other key aspects of care.
Eplerenone May Improve Albumin Excretion in T2D With Acceptable Safety
Research suggests the use of additional treatment options, such as the mineralocorticoid receptor antagonist eplerenone, might prevent or delay overt diabetic nephropathy.
Recurrent Hyperkalemia a Major Cause of Hospitalization, Especially in CKD
In a European study, approximately one-third of hospitalizations involving patients with recurrent hyperkalemia directly related to serum potassium elevation.
Canagliflozin Found Not to Increase Hyperkalemia Risk
Final data from the CANVAS trials show that serious hyperkalemia is an uncommon occurrence.
-
Loading...
-
Loading...
Next post in Hyperkalemia
